Search Within

GDMT, Medicine

  1. "Biostatistics Service"
Formats
  1. Journal Article (205)
  2. Meeting Abstract (107)
  3. Book Section (1)
  4. Research Letter (1)
Groups
  1. Biostatistics Service (314)
  2. Department of Medicine (314)
  3. Epidemiology and Biostatistics (314)
  4. Gynecology Disease Management Team (314)
  5. Solid Tumor Oncology Division (310)
  6. Gynecologic Medicine Service (299)

More Groups

People
  1. Alexia Iasonos (186)
  2. Carol Aghajanian (143)
  3. Qin Zhou (143)
  4. Dennis Chi (81)
  5. Martee Hensley (80)
  6. Nadeem Abu-Rustum (78)

More People

Years
  1. 2025 (8)
  2. 2024 (25)
  3. 2023 (30)
  4. 2022 (29)
  5. 2021 (17)
  6. 2020 (24)

More Years

Publications
  1. Gynecologic Oncology (84)
  2. Journal of Clinical Oncology (74)
  3. International Journal of Gynecological Cancer (34)
  4. Cancer (12)
  5. Clinical Cancer Research (11)
  6. Breast Cancer Research and Treatment (7)

More Publications

Publishers
  1. Elsevier Inc. (93)
  2. American Society of Clinical Oncology (82)
  3. Lippincott Williams & Wilkins (36)
  4. American Association for Cancer Research (21)
  5. Wiley Blackwell (16)
  6. Springer (13)

More Publishers

Results (314)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase II trial of durvalumab with or without tremelimumab in patients with persistent or recurrent endometrial carcinoma and endometrial carcinosarcoma
    Meeting Abstract

    Rubinstein, M. M.; Caird, I.; Zhou, Q.; Iasonos, A.; Friedman, C. F.; Cadoo, K. A.; Konner, J. A.; O'Cearbhaill, R. E.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • DNA damage response pathway alterations and clinical outcome in leiomyosarcoma
    Meeting Abstract

    Rosenbaum, E.; Jonsson, P.; Seier, K.; Chi, P.; Dickson, M. A.; Gounder, M. M.; Kelly, C. M.; Keohan, M. L.; Qin, L. X.; Hensley, M. L.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Efficacy and safety of pembrolizumab in patients with advanced adrenocortical carcinoma
    Meeting Abstract

    Raj, N. P.; Zheng, Y.; Kelly, V.; Katz, S.; Chou, J. F.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Ariyan, C. E.; Untch, B. R.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Delays from neoadjuvant chemotherapy to interval debulking surgery and survival in ovarian cancer
    Meeting Abstract

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Filippova, O. T.; Chi, D.; Zivanovic, O.; Sonoda, Y.; Gardner, G. J.; Broach, V.; O'Cearbhaill, R. E.; more...
    Journal of Clinical Oncology (2019)

    Fulltext@MSK | Save
  • Subsequent therapies and survival after immunotherapy in recurrent ovarian cancer
    Journal Article

    Liu, Y. L.; Zhou, Q.; Iasonos, A.; Emengo, V. N.; Friedman, C.; Konner, J. A.; O'Cearbhaill, R. E.; Aghajanian, C.; Zamarin, D.
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A descriptive report of outcomes of primary mucinous ovarian cancer patients receiving either an adjuvant gynecologic or gastrointestinal chemotherapy regimen
    Journal Article

    Schlappe, B. A.; Zhou, Q. C.; O'Cearbhaill, R.; Iasonos, A.; Soslow, R. A.; Abu-Rustum, N. R.; Mueller, J. J.
    International Journal of Gynecological Cancer (2019)

    Fulltext@MSK | Save
  • Immunophenotype and response to immunotherapy of RET-rearranged lung cancers
    Journal Article

    Offin, M.; Guo, R.; Wu, S. L.; Sabari, J.; Land, J. D.; Ni, A.; Montecalvo, J.; Halpenny, D. F.; Buie, L. W.; Pak, T.; more...
    JCO Precision Oncology (2019)

    Fulltext@MSK | Save
  • A phase II trial of sorafenib and dacarbazine for leiomyosarcoma, synovial sarcoma, and malignant peripheral nerve sheath tumors
    Journal Article

    D'Adamo, D. R.; Dickson, M. A.; Keohan, M. L.; Carvajal, R. D.; Hensley, M. L.; Hirst, C. M.; Ezeoke, M. O.; Ahn, L.; Qin, L. X.; Antonescu, C. R.; more...
    The Oncologist (2019)

    Fulltext@MSK | Save
  • Early disease progression and treatment discontinuation in patients with advanced ovarian cancer receiving immune checkpoint blockade
    Journal Article

    Boland, J. L.; Zhou, Q.; Martin, M.; Callahan, M. K.; Konner, J.; O'Cearbhaill, R. E.; Friedman, C. F.; Tew, W.; Makker, V.; Grisham, R. N.; more...
    Gynecologic Oncology (2019)

    Fulltext@MSK | Save
  • A phase I study of concomitant galinpepimut-s (GPS) in combination with nivolumab (nivo) in patients (pts) with WT1+ ovarian cancer (OC) in second or third remission
    Meeting Abstract

    O'Cearbhaill, R. E.; Gnjatic, S.; Aghajanian, C.; Iasonos, A.; Konner, J. A.; Losada, N.; Sarasohn, D.; Rasalan, T.; Tew, W. P.; Zamarin, D.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save